$77.22
2.413.22%
At close: May 13, 5:00 PM EST
$77.22
N/A
After Hours: 4:00 PM EST
Cytokinetics Inc Earnings Estimates
CYTKNASDAQ
Cytokinetics Earnings Estimates, EPS & Revenue | NASDAQ:CYTK
Cytokinetics (CYTK) is scheduled to report Q2 earnings on August 6, 2026. Analysts estimate EPS of $-1.66 and quarterly revenue of $17.14M.
In the most recent quarter (Q1), Cytokinetics reported EPS of $-1.67, missing estimates of $-1.65 by 0.01%. Revenue came in at $19.36M, exceeding the estimate of $8.49M by 1.28%.
Cytokinetics has missed EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Cytokinetics has averaged an EPS surprise of 0.07% and a revenue surprise of 6.73%.
Earnings Date
Aug 6
EPS Estimate
$-1.660
Quarterly Revenue Estimate
$17.14M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$105.81M
Cytokinetics Earnings History
Analyze the earnings history of Cytokinetics using advanced sorting and filters.
Loading calendar...
Cytokinetics (CYTK) Earnings Per Share
The chart below shows Cytokinetics's reported EPS compared to analyst estimates over recent quarters.
Cytokinetics (CYTK) Revenue
The chart below shows Cytokinetics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Cytokinetics (NASDAQ:CYTK) reporting earnings?
Cytokinetics (CYTK) is scheduled to report earnings on August 6, 2026. The last reported earnings were for reported on May 5, 2026 for Q1.
What were the latest earnings per share (EPS) for Cytokinetics (NASDAQ:CYTK)?
The Actual EPS was $-1.67, which missed the estimate of $-1.65.
What were Cytokinetics’s (NASDAQ:CYTK) revenues?
The Actual Revenue was $19.36M, which beat the estimate of $8.49M.
